From January to July 2023, Russian manufacturers produced 398.6 billion rubles’ worth of ready-made drugs (manufacturer’s prices, VAT included), down 0.3% from the same period in 2022. In physical terms, 2.26 billion packages were produced, down 6.9% from January–July 2022. If calculated in minimum dosage units (MDU), the production volume was 44.8 billion, down 2.3%.

Comprehensive ranking of logistics operators in the Russian pharmaceutical market in 2022.

Almost 80% of Russian doctors oppose the initiatives to increase the birth rate proposed by the Ministry of Health and the State Duma of the Russian Federation, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors. In particular, 47.3% of the respondents consider these measures “perfunctory”, since only an increased welfare of the population and more social benefits can guarantee a decreased abortion rate.

In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022. In physical terms, the production volume was 1.97 billion packages, down 8.2%, or 39.0 billion minimum dosage units (MDU), down 3.8%.

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022. In physical terms, the production volume was 1.64 billion packages, down 9.7% from January–May 2022. If calculated in minimum dosage units (MDU), Russian manufacturers produced 32.2 billion MDUs, down 3.9% from January–May 2022.

In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand). This year, however, the online segment has entered a phase of stagnation due to the fact that further development might no longer be possible, when the experimental online sale of prescription drugs launched on March 1, 2023 is stalling.

Russian Pharmacy Chain Rankings in Q1 2023

Russian Pharmaceutical Distributor Rankings in Q1 2023

In Q1 2023, Russian manufactures produced 167.6 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 9.8% from Q1 2022. In physical terms, the production was 0.98 billion packages, down 10.3% from Q1 2022. If calculated in minimum dosage units (MDU), the production went down 3.9%, with 19.1 billion MDUs.

39.6% of physicians think they could leave public healthcare in favor of a private medical institution due to “unjustifiably low salaries”, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors. Another popular reason is “excessive workload and constant overwork”, voted by 31.3% of the respondents.